{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:39:24Z","timestamp":1792805964585,"version":"4.5.0"},"reference-count":175,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neuroinflammation is a physiological response aimed at maintaining the homodynamic balance and providing the body with the fundamental resource of adaptation to endogenous and exogenous stimuli. Although the response is initiated with protective purposes, the effect may be detrimental when not regulated. The physiological control of neuroinflammation is mainly achieved via regulatory mechanisms performed by particular cells of the immune system intimately associated with or within the nervous system and named \u201cnon-neuronal cells.\u201d In particular, mast cells (within the central nervous system and in the periphery) and microglia (at spinal and supraspinal level) are involved in this control, through a close functional relationship between them and neurons (either centrally, spinal, or peripherally located). Accordingly, neuroinflammation becomes a worsening factor in many disorders whenever the non-neuronal cell supervision is inadequate. It has been shown that the regulation of non-neuronal cells\u2014and therefore the control of neuroinflammation\u2014depends on the local \u201con demand\u201d synthesis of the endogenous lipid amide Palmitoylethanolamide and related endocannabinoids. When the balance between synthesis and degradation of this bioactive lipid mediator is disrupted in favor of reduced synthesis and\/or increased degradation, the behavior of non-neuronal cells may not be appropriately regulated and neuroinflammation exceeds the physiological boundaries. In these conditions, it has been demonstrated that the increase of endogenous Palmitoylethanolamide\u2014either by decreasing its degradation or exogenous administration\u2014is able to keep neuroinflammation within its physiological limits. In this review the large number of studies on the benefits derived from oral administration of micronized and highly bioavailable forms of Palmitoylethanolamide is discussed, with special reference to neuroinflammatory disorders.<\/jats:p>","DOI":"10.3390\/ijms21249526","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T09:12:57Z","timestamp":1608023577000},"page":"9526","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries\u2014A Systematic Review"],"prefix":"10.3390","volume":"21","author":[{"given":"Stefania","family":"Petrosino","sequence":"first","affiliation":[{"name":"Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Napoli, Italy"},{"name":"Epitech Group SpA, Via Einaudi 13, 35030 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniello","family":"Schiano Moriello","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Napoli, Italy"},{"name":"Epitech Group SpA, Via Einaudi 13, 35030 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: Activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri3392","article-title":"Neuroinflammation: Inflammatory brain drain","volume":"13","author":"Bordon","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fnins.2015.00201","article-title":"Editorial: Neuroinflammation and behavior","volume":"9","author":"Sominsky","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-013-1092-y","article-title":"The role of mast cells in neuroinflammation","volume":"125","author":"Nelissen","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.12659\/MSMBR.893093","article-title":"Mast cells and neuroinflammation","volume":"20","author":"Dong","year":"2014","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"918917","DOI":"10.1100\/tsw.2001.20","article-title":"Why Homeodynamics, Not Homeostasis?","volume":"1","author":"Lloyd","year":"2001","journal-title":"Sci. World J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2015.00051","article-title":"Dual role of microglia in health and disease: Pushing the balance toward repair","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2174\/1871527313666141130224206","article-title":"Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: A review","volume":"13","author":"Skaper","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fncel.2014.00120","article-title":"Histamine: A new immunomodulatory player in the neuron-glia crosstalk","volume":"8","author":"Rocha","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fncel.2014.00152","article-title":"Microglia change from a reactive to an age-like phenotype with the time in culture","volume":"8","author":"Caldeira","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neubiorev.2017.05.001","article-title":"Mast cells in neuroinflammation and brain disorders","volume":"79","author":"Hendriksen","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","article-title":"Microglia and neurodegeneration: The role of systemic inflammation","volume":"61","author":"Cunningham","year":"2013","journal-title":"Glia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1096\/fj.11-197194","article-title":"Microglia and mast cells: Two tracks on the road to neuroinflammation","volume":"26","author":"Skaper","year":"2012","journal-title":"FASEB J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1073858416687249","article-title":"Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons","volume":"23","author":"Skaper","year":"2017","journal-title":"Neuroscientist"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e13270","DOI":"10.1111\/apha.13270","article-title":"Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications","volume":"226","author":"Llansola","year":"2019","journal-title":"Acta Physiol. (Oxf.)"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Farhadian, S., Glick, L.R., Vogels, C.B.F., Thomas, J., Chiarella, J., Casanovas-Massana, A., Zhou, J., Odio, C., Vijayakumar, P., and Geng, B. (2020). Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol., 20.","DOI":"10.1186\/s12883-020-01812-2"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain Regulation by Non-neuronal Cells and Inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fncel.2019.00263","article-title":"Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies","volume":"13","author":"Refolo","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncel.2018.00072","article-title":"An Inflammation-Centric View of Neurological Disease: Beyond the Neuron","volume":"12","author":"Skaper","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1098\/rstb.2011.0391","article-title":"Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","article-title":"Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator","volume":"48","author":"Skaper","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0021-9258(18)97531-9","article-title":"Fatty acid amides of ethanolamine in mammalian tissues","volume":"240","author":"Bachur","year":"1965","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.12170","article-title":"Mast cells, glia and neuroinflammation: Partners in crime?","volume":"141","author":"Skaper","year":"2014","journal-title":"Immunology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","article-title":"Peripheral gating of pain signals by endogenous lipid mediators","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","article-title":"N-Palmitoylethanolamine and Neuroinflammation: A Novel Therapeutic Strategy of Resolution","volume":"52","author":"Skaper","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-5793(95)01194-J","article-title":"Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain","volume":"375","author":"Schmid","year":"1995","journal-title":"FEBS Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1523\/JNEUROSCI.23-21-07767.2003","article-title":"Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility","volume":"23","author":"Franklin","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(01)01182-7","article-title":"Receptor-dependent formation of endogenous cannabinoids in cortical neurons","volume":"425","author":"Stella","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1074\/jbc.M110813200","article-title":"Astrocytes in culture produce anandamide and other acylethanolamides","volume":"277","author":"Walter","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2007.05.015","article-title":"Microglia produce and hydrolyze palmitoylethanolamide","volume":"54","author":"Muccioli","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","article-title":"Endocannabinoids control spasticity in a multiple sclerosis model","volume":"15","author":"Baker","year":"2001","journal-title":"FASEB J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington\u2019s disease","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/abbi.1999.1410","article-title":"Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina","volume":"370","author":"Bisogno","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbrc.2005.03.095","article-title":"Finding of endocannabinoids in human eye tissues: Implications for glaucoma","volume":"330","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.plefa.2006.08.002","article-title":"Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration","volume":"75","author":"Matias","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0006-291X(79)91281-6","article-title":"N-Acylethanolamine accumulation in infarcted myocardium","volume":"90","author":"Epps","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/abbi.1998.0688","article-title":"Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis","volume":"354","author":"Kondo","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2009.02137.x","article-title":"Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis","volume":"30","author":"Caraceni","year":"2010","journal-title":"Liver Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-3084(02)00158-5","article-title":"N-Acylethanolamines in human reproductive fluids","volume":"121","author":"Schuel","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.bjp.0704339","article-title":"Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice","volume":"134","author":"Capasso","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuropharm.2005.01.001","article-title":"Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies","volume":"48","author":"Darmani","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj3460369","article-title":"Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells","volume":"346","author":"Berdyshev","year":"2000","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1398-9995.2009.02254.x","article-title":"Protective role of palmitoylethanolamide in contact allergic dermatitis","volume":"65","author":"Petrosino","year":"2010","journal-title":"Allergy"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ghafouri, N., Ghafouri, B., Larsson, B., Turkina, M.V., Karlsson, L., Fowler, C.J., and Gerdle, B. (2011). High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027257"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.pain.2013.05.002","article-title":"Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity","volume":"154","author":"Ghafouri","year":"2013","journal-title":"Pain"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0014-5793(98)00046-5","article-title":"Isotope dilution GC\/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma","volume":"422","author":"Giuffrida","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ab.2006.11.027","article-title":"Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry","volume":"361","author":"Schreiber","year":"2007","journal-title":"Anal. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jchromb.2009.04.010","article-title":"Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry","volume":"877","author":"Balvers","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/bph.13084","article-title":"The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels","volume":"173","author":"Petrosino","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00216-010-4103-z","article-title":"Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry","volume":"398","author":"Lam","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnins.2018.00145","article-title":"Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain","volume":"12","author":"Herrera","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrneurol.2015.13","article-title":"The role of inflammation in perinatal brain injury","volume":"11","author":"Hagberg","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.100.5.425","article-title":"The effect of egg yolk in diets on anaphylactic arthritis (passive Arthus phenomenon) in the guinea pig","volume":"100","author":"Coburn","year":"1954","journal-title":"J. Exp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/ja01577a066","article-title":"The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent","volume":"79","author":"Kuehl","year":"1957","journal-title":"J. Am. Chem. Soc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cbdv.200790161","article-title":"The N-acylethanolamine-mediated regulatory pathway in plants","volume":"4","author":"Kilaru","year":"2007","journal-title":"Chem. Biodivers."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.phytochem.2005.06.014","article-title":"N-acylethanolamines in seeds of selected legumes","volume":"66","author":"Venables","year":"2005","journal-title":"Phytochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/ac403352e","article-title":"Development and validation of a sensitive UPLC-ESI-MS\/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids","volume":"86","author":"Nording","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrs.2016.04.007","article-title":"2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation","volume":"108","author":"Impellizzeri","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: The big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-8069-5-35","article-title":"Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain","volume":"5","author":"Guasti","year":"2009","journal-title":"Mol. Pain"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2017.02.016","article-title":"Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1","volume":"62","author":"Henry","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_70","first-page":"1546","article-title":"Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10787-013-0191-7","article-title":"Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain","volume":"22","author":"Skaper","year":"2014","journal-title":"Inflammopharmacology"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cordaro, M., Cuzzocrea, S., and Crupi, R. (2020). An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel), 9.","DOI":"10.3390\/antiox9030216"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"125218","DOI":"10.1016\/j.foodchem.2019.125218","article-title":"Food database of N-acyl-phosphatidylethanolamines, N-acylethanolamines and endocannabinoids and daily intake from a Western, a Mediterranean and a vegetarian diet","volume":"300","author":"Ferracane","year":"2019","journal-title":"Food Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2760(97)00132-X","article-title":"Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry","volume":"1389","author":"Sepe","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-014-0136-0","article-title":"Micronized\/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain","volume":"11","author":"Impellizzeri","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fphar.2018.00249","article-title":"Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect","volume":"9","author":"Petrosino","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Beggiato, S., Tomasini, M.C., Cassano, T., and Ferraro, L. (2020). Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer\u2019s Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020428"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/fsn3.392","article-title":"Safety of micronized palmitoylethanolamide (microPEA): Lack of toxicity and genotoxic potential","volume":"5","author":"Nestmann","year":"2017","journal-title":"Food Sci. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson\u2019s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1007\/s12035-018-0959-2","article-title":"N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice","volume":"55","author":"Crupi","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/187153007781662521","article-title":"Neuroinflammation and its modulation by flavonoids","volume":"7","author":"Vafeiadou","year":"2007","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.09.002","article-title":"Luteolin as an anti-inflammatory and neuroprotective agent: A brief review","volume":"119","author":"Nabavi","year":"2015","journal-title":"Brain Res. Bull."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3109\/13880209.2013.792849","article-title":"Polydatin: A review of pharmacology and pharmacokinetics","volume":"51","author":"Du","year":"2013","journal-title":"Pharm. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Esposito, E., Impellizzeri, D., Mazzon, E., Paterniti, I., and Cuzzocrea, S. (2012). Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson\u2019s disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041880"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/1871527314666150821102823","article-title":"The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson\u2019s Disease Model","volume":"14","author":"Siracusa","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2016.09.004","article-title":"Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence","volume":"113","author":"Avagliano","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1871527316666170321124949","article-title":"Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson\u2019s Disease","volume":"16","author":"Brotini","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"Russo","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e1419","DOI":"10.1038\/cddis.2014.376","article-title":"Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer\u2019s disease","volume":"5","author":"Scuderi","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-017-0076-4","article-title":"Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer\u2019s disease by exerting anti-inflammatory and neuroprotective effects","volume":"8","author":"Scuderi","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4720532","DOI":"10.1155\/2018\/4720532","article-title":"Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer\u2019s Disease: In Vitro and In Vivo Evidence","volume":"2018","author":"Bronzuoli","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Facchinetti, R., Valenza, M., Bronzuoli, M.R., Menegoni, G., Ratano, P., Steardo, L., Campolongo, P., and Scuderi, C. (2020). Looking for a Treatment for the Early Stage of Alzheimer\u2019s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113802"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40520-016-0533-6","article-title":"PEALut efficacy in mild cognitive impairment: Evidence from a SPECT case study!","volume":"28","author":"Naro","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1460-9568.2008.06377.x","article-title":"Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide","volume":"28","author":"Petrosino","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-019-1514-4","article-title":"A Co-Ultramicronized Palmitoylethanolamide\/Luteolin Composite Mitigates Clinical Score and Disease-Relevant Molecular Markers in a Mouse Model of Experimental Autoimmune Encephalomyelitis","volume":"16","author":"Contarini","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s13311-016-0420-z","article-title":"Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-\u03b21a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis","volume":"13","author":"Orefice","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2174\/1871527311201070933","article-title":"Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: A case report","volume":"11","author":"Clemente","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1073\/pnas.1600251113","article-title":"Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy","volume":"113","author":"Palma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1871527318666190131121827","article-title":"Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: A Pilot Study to Possible Future Implications of Treatment","volume":"18","author":"Onesti","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cns.12648","article-title":"Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide\/Luteolin in a Mouse Model of Autism and in a Case Report of Autism","volume":"23","author":"Bertolino","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2018.09.003","article-title":"Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf\/J mice: Contribution of central and peripheral mechanisms","volume":"74","author":"Cristiano","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_102","first-page":"325061","article-title":"Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases","volume":"2015","author":"Antonucci","year":"2015","journal-title":"Case Rep. Psychiatry"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: Involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors","volume":"139","author":"Costa","year":"2008","journal-title":"Pain"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871527311312010008","article-title":"Non-neuronal cell modulation relieves neuropathic pain: Efficacy of the endogenous lipid palmitoylethanolamide","volume":"12","author":"Bettoni","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_105","first-page":"328797","article-title":"Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: Pain relief and neuroprotection share a PPAR-alpha-mediated mechanism","volume":"2013","author":"Pacini","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1871527311312010009","article-title":"Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial\/microglial phenotypical changes in mice","volume":"12","author":"Luongo","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13041-015-0139-5","article-title":"Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice","volume":"8","author":"Guida","year":"2015","journal-title":"Mol. Brain"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Di Cesare Mannelli, L., Pacini, A., Corti, F., Boccella, S., Luongo, L., Esposito, E., Cuzzocrea, S., Maione, S., Calignano, A., and Ghelardini, C. (2015). Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128080"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2011.08.010","article-title":"Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain","volume":"153","author":"Sasso","year":"2012","journal-title":"Pain"},{"key":"ref_110","first-page":"894732","article-title":"Delay of morphine tolerance by palmitoylethanolamide","volume":"2015","author":"Corti","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.09.023","article-title":"Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway","volume":"121","author":"Boccella","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Fusco, R., Gugliandolo, E., Campolo, M., Evangelista, M., Di Paola, R., and Cuzzocrea, S. (2017). Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178553"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Peritore, A.F., Siracusa, R., Fusco, R., Gugliandolo, E., D\u2019Amico, R., Cordaro, M., Crupi, R., Genovese, T., Impellizzeri, D., and Cuzzocrea, S. (2020). Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103509"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Siracusa, R., Fusco, R., Cordaro, M., Peritore, A.F., D\u2019Amico, R., Gugliandolo, E., Crupi, R., Genovese, T., Evangelista, M., and Di Paola, R. (2020). The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207700"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","article-title":"Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis","volume":"13","author":"Gatti","year":"2012","journal-title":"Pain Med."},{"key":"ref_116","first-page":"854560","article-title":"Short-term efficacy of ultramicronized palmitoylethanolamide in peripheral neuropathic pain","volume":"2014","author":"Cocito","year":"2014","journal-title":"Pain Res. Treat."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jcph.1070","article-title":"N-Palmitoyl Ethanol Amide Pharmacological Treatment in Patients with Nonsurgical Lumbar Radiculopathy","volume":"58","author":"Chirchiglia","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Passavanti, M.B., Fiore, M., Sansone, P., Aurilio, C., Pota, V., Barbarisi, M., Fierro, D., and Pace, M.C. (2017). The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: A pilot study comparing prospective and retrospective observational arms. BMC Anesthesiol., 17.","DOI":"10.1186\/s12871-017-0461-9"},{"key":"ref_119","first-page":"1486010","article-title":"Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome","volume":"2017","author":"Paladini","year":"2017","journal-title":"Pain Res. Treat."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40122-019-00140-9","article-title":"Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study","volume":"9","author":"Scaturro","year":"2020","journal-title":"Pain Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1871527317666180420143830","article-title":"Ultra-micronized Palmitoylethanolamide Effects on Sleep-wake Rhythm and Neuropathic Pain Phenotypes in Patients with Carpal Tunnel Syndrome: An Open-label, Randomized Controlled Study","volume":"17","author":"Evangelista","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/j.pain.0000000000000220","article-title":"Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: Role of mast cells","volume":"157","author":"Iuvone","year":"2016","journal-title":"Pain"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2010.01.008","article-title":"Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations","volume":"150","author":"Indraccolo","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_124","first-page":"453","article-title":"Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: Preliminary results","volume":"65","author":"Soave","year":"2013","journal-title":"Minerva Ginecol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejogrb.2011.04.011","article-title":"Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: A pilot study","volume":"158","author":"Cobellis","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2013.01.009","article-title":"The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain","volume":"168","author":"Giugliano","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpag.2014.12.011","article-title":"Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea","volume":"28","author":"Tartaglia","year":"2015","journal-title":"J. Pediatric Adolesc. Gynecol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/IJWH.S204275","article-title":"Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide\/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study","volume":"11","author":"Pontis","year":"2019","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_129","first-page":"193","article-title":"Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache","volume":"9","author":"Chirchiglia","year":"2016","journal-title":"Int. Med. Case Rep. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fneur.2018.00674","article-title":"Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine with Aura: A Pilot Study","volume":"9","author":"Chirchiglia","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3938640","DOI":"10.1155\/2020\/3938640","article-title":"Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study","volume":"2020","author":"Papetti","year":"2020","journal-title":"Pain Res. Manag."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","article-title":"Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies","volume":"4","author":"Skaper","year":"2015","journal-title":"Pain Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1871527318666190227205359","article-title":"Ultramicronized Palmitoylethanolamide (um-PEA) as add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients","volume":"18","author":"Schweiger","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"35552","DOI":"10.1074\/jbc.M106261200","article-title":"Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance","volume":"276","author":"Ueda","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bcp.2009.04.024","article-title":"N-acylethanolamines, anandamide and food intake","volume":"78","author":"Hansen","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/biof.1158","article-title":"Classical endocannabinoid-like compounds and their regulation by nutrients","volume":"40","author":"Kleberg","year":"2014","journal-title":"Biofactors"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1007\/BF01972748","article-title":"A proposed autacoid mechanism controlling mastocyte behaviour","volume":"39","author":"Aloe","year":"1993","journal-title":"Agents Actions"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","article-title":"Nerve growth factor: From neurotrophin to neurokine","volume":"19","author":"Skaper","year":"1996","journal-title":"Trends Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"Melck","year":"2001","journal-title":"Biochem. J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-019-1671-5","article-title":"Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity","volume":"16","author":"Petrosino","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(01)02934-9","article-title":"Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors","volume":"506","author":"Davis","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u201cEntourage\u201d effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Zygmunt, P.M., Ermund, A., Movahed, P., Andersson, D.A., Simonsen, C., J\u00f6nsson, B.A.G., Blomgren, A., Birnir, B., Bevan, S., and Eschalier, A. (2013). Monoacylglycerols activate TRPV1\u2014A link between phospholipase C and TRPV1. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081618"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Fu","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1038\/s41598-017-07519-8","article-title":"A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum","volume":"7","author":"Musella","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Fride","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bph.12029","article-title":"Activation and desensitization of TRPV1 channels in sensory neurons by the PPAR\u03b1 agonist palmitoylethanolamide","volume":"168","author":"Ambrosino","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.phrs.2014.06.015","article-title":"Functional and biochemical interaction between PPAR\u03b1 receptors and TRPV1 channels: Potential role in PPAR\u03b1 agonists-mediated analgesia","volume":"87","author":"Ambrosino","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41598-017-00342-1","article-title":"Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: Involvement of the CB2 receptor","volume":"7","author":"Guida","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1582-4934.2011.01267.x","article-title":"Palmitoylethanolamide counteracts reactive astrogliosis induced by \u03b2-amyloid peptide","volume":"15","author":"Scuderi","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1742-2094-9-49","article-title":"Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-\u03b1","volume":"9","author":"Scuderi","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3389\/fneur.2018.00860","article-title":"Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson\u2019s Disease","volume":"9","author":"Parra","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/1673-5374.293147","article-title":"Glial-derived transforming growth factor \u03b21 (TGF-\u03b21): A key factor in multiple sclerosis neuroinflammation","volume":"16","author":"Guevara","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2014.02.006","article-title":"Molecular mechanisms linking neuroinflammation and neurodegeneration in MS","volume":"262 Pt A","author":"Ellwardt","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-017-1028-x","article-title":"Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia","volume":"14","author":"Mishra","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp-2018-318868","article-title":"Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase","volume":"90","author":"Oeckl","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/mp.2014.59","article-title":"Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis","volume":"20","author":"Masi","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_165","first-page":"265","article-title":"Neuroinflammation in autism spectrum disorders","volume":"9","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Torrado-Carvajal, A., Toschi, N., Albrecht, D.S., Chang, K., Akeju, O., Kim, M., Edwards, R.R., Zhang, Y., Hooker, J.M., and Duggento, A. (2020). Thalamic neuroinflammation as a reproducible and discriminating signature for chronic low back pain. Pain.","DOI":"10.1097\/j.pain.0000000000002108"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","article-title":"Roles of Inflammation, Neurogenic inflammation, and Neuroinflammation in Pain","volume":"33","author":"Matsuda","year":"2019","journal-title":"J. Anesth."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1871527318666190703110036","article-title":"Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain\u2014Sciatica","volume":"18","author":"Cruccu","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-017-0828-3","article-title":"Macrophage and nerve interaction in endometriosis","volume":"14","author":"Wu","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fncel.2019.00353","article-title":"Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome","volume":"13","author":"Theoharides","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Ryabkova, V.A., Churilov, L.P., and Shoenfeld, Y. (2019). Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205164"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2015.100","article-title":"Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome","volume":"11","author":"Littlejohn","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Tauber, S.C., Djukic, M., Gossner, J., Eiffert, H., Br\u00fcck, W., and Nau, R. (2020). Sepsis-associated encephalopathy and septic encephalitis: An update. Expert Rev. Anti-Infect. Ther., 1\u201317.","DOI":"10.1080\/14787210.2020.1812384"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3389\/fimmu.2018.02671","article-title":"Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice with Bacterial Meningitis","volume":"9","author":"Heide","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fnins.2019.00527","article-title":"Broad Lipidomic and Transcriptional Changes of Prophylactic PEA Administration in Adult Mice","volume":"13","author":"Lerner","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/24\/9526\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:09Z","timestamp":1760179509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/24\/9526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":175,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21249526"],"URL":"https:\/\/doi.org\/10.3390\/ijms21249526","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}